Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Sight Sciences Sees FY23 Revenue $89M-$94M Vs $91.22M Est

2023 Financial Guidance Sight Sciences projects revenue for the full year 2023 to range from $89 million to $94 million, which represents growth of

byHappy Mohamed

March 13, 2023

1 minute read

2023 Financial Guidance

Sight Sciences projects revenue for the full year 2023 to range from $89 million to $94 million, which represents growth of approximately 25% to 32% compared to 2022.

Cowen & Co. Upgrades Paychex to Outperform, Raises Price Target to $145

By Benzinga Newsdesk

Today, 6:15 PM

Cowen & Co. analyst Bryan Bergin upgrades Paychex (NASDAQ:PAYX) from Market Perform to Outperform and raises the price target from $130 to $145.

PAYX

Independent Bank Gr Q3 EPS $1.22 Misses $1.30 Estimate, Sales $144.03M Miss $147.68M Estimate

By Benzinga Newsdesk

Today, 6:15 PM

Independent Bank Gr (NASDAQ:IBTX) reported quarterly earnings of $1.22 per share which missed the analyst consensus estimate of $1.30 by 6.15 percent. This is a 11.59 percent decrease over earnings of $1.38 per share

IBTX

Avid Bioservices Q4 EPS $1.65 Up From $(0.04) YoY, Sales $31.23M Beat $28.96M Estimate

By Benzinga Newsdesk

Today, 6:15 PM

Avid Bioservices (NASDAQ:CDMO) reported quarterly earnings of $1.65 per share. This is a 4225 percent increase over losses of $(0.04) per share from the same period last year. The company reported quarterly sales of

CDMO